DRUGSCIENCE LTD
Advance education of public in harms of drug taking to prevent & mitigate suffering caused by drug harms & assoc behaviours. Promote good health of public through advice to public & practitioners impacted by drug taking in any way. Promote research in subject of drugs & drug taking for public benefit & into effects on public & society in general, whether physical, medical, psychological or social.
Objects
1. TO ADVANCE THE EDUCATION OF THE PUBLIC IN THE HARMS OF DRUG TAKING TO HELP PREVENT AND MITIGATE THE SUFFERING CAUSED BY DRUG HARMS AND ASSOCIATED BEHAVIOURS;2. TO PROMOTE THE GOOD HEALTH OF THE GENERAL PUBLIC BY PROVIDING ADVICE TO THE PUBLIC AND PRACTITIONERS WHO ARE IMPACTED BY DRUG TAKING IN ANYWAY;3. TO PROMOTE RESEARCH, FOR THE BENEFIT OF THE PUBLIC, IN THE SUBJECT OF DRUGS AND DRUG TAKING AND INTO ITS EFFECTS ON THE PUBLIC AND SOCIETY IN GENERAL, WHETHER PHYSICAL, MEDICAL, PSYCHOLOGICAL OR SOCIAL.
Financial health, per its FY2025 accounts
The accounts state that the charity reported a deficit of £255,395 for the year ended 30 June 2025, resulting in a decrease in total net assets from £947,403 to £692,008. The trustees' report notes that the priority is to secure financial stability and develop funding avenues to ensure the organisation can continue to meet its charitable objectives. The independent examiner confirmed that no matters came to their attention giving cause to believe the accounts were not prepared in accordance with applicable requirements.
What the accounts disclose
“The cost of raising funds for the period (including allocated support costs) totalled £149,888 (2024: £153,428).”
“The trustees believe that the charity should target to hold unrestricted financial reserves equivalent to a minimum of 2 year's core costs. This is estimated to be £160,000.”
Policies the charity declares
- Bullying and harassment policy and procedures
- Campaigns and political activity policy and procedures
- Complaints policy and procedures
- Conflicting interests
- Engaging external speakers at charity events policy and procedures
- Financial reserves policy and procedures
- Internal charity financial controls policy and procedures
- Internal risk management policy and procedures
- Paying staff
- Risk management
- Serious incident reporting policy and procedures
- Social media policy and procedures
- Trustee conflicts of interest policy and procedures
- Trustee expenses policy and procedures
- Volunteer management
Structured financials (annual return, FY ending 30/06/2024)
Trustees
- Countess Dinah Esther Ashley-Cooper
- Jeff Smith
- Owen Medler
- Prof Joanna Nuttall
- Professor David Nutt
- Robert Velarde
- Robin Firth
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 30/06/2025 | £380k | £636k |
| 30/06/2024 | £705k | £568k |
| 30/06/2023 | £916k | £707k |
| 30/06/2022 | £999k | £692k |
| 30/06/2021 | £622k | £552k |
Common questions
Is DRUGSCIENCE LTD financially healthy?
Per its FY2025 accounts: The accounts state that the charity reported a deficit of £255,395 for the year ended 30 June 2025, resulting in a decrease in total net assets from £947,403 to £692,008. The trustees' report notes that the priority is to secure financial stability and develop funding avenues to ensure the organisation can continue to meet its charitable objectives. The independent examiner confirmed that no matters came to their attention giving cause to believe the accounts were not prepared in accordance with applicable requirements. Its FY2025 accounts were independently examined.